Health Care and Profits, a Poor Mix / NY Times
An excellent piece discusses how turning over aspects of healthcare to private industry led to greater costs without accompanying benefits, and compares the US with other first world countries.
Similar Posts
Get vaccinated, set an example, then you keep getting COVID. Follow the science. It’s cause the vaccine has negative efficacy, dummy.
AP: HHS Secretary Becerra Tests Positive For COVID-19 Again President Joe Biden’s top health official has again tested positive for COVID-19, less than a month after he came down with virus symptoms while on a trip to Germany. U.S. Health Secretary Xavier Becerra woke up with symptoms again Monday morning and tested positive afterward, spokeswoman…
Medical Professionals Not Sufficiently Vaccinated for Flu in Canberra, Australia / Canberra Times
Canberra, Australia’s capital, has about 365,000 people and has a medical school. Its health staff totals 5,122 people. Only 48% were vaccinated against the flu this year, down from 60% during the swine flu pandemic of 2009. But is this a problem? ACT Health said there have been fewer than five deaths a year for…
How you can receive early effective treatment for Covid
US Doctor groups willing to treat Covid patients with appropriate medications: 1. Dr. Zev Zelenko‘s new website. He pioneered HCQ treatments in the US: https://www.vladimirzelenkomd.com/ 2. Dr Peter McCullough et al’s protocol–please scroll down to the gray area to click on a small spot to download the full text https://rcm.imrpress.com/EN/10.31083/j.rcm.2020.04.264 3. version 7 of iMASK protocol 4. …
Coronavirus: mortality rates, questionable data, treatment. Part 3
Mortality rates and spread We have had 5 weeks of quarantine. I earlier pointed out that there is an average 4 week lag between exposure to SARS-CoV-2 and death (or recovery) for those with a significant Covid-19 illness. So, if the quarantine was going to work as planned, we should now be able to see…
Public Health Gone Awry: Birth Dose of Hepatitis B Vaccine (IOM chimes in on lack of good vaccine data)
Hepatitis B is a serious disease. It is highly prevalent in many countries in Asia (nearly 10% of Chinese carried the illness in 1992), but fortunately is of low prevalence in the US. Per CDC, the overall reported US incidence rate for 2013 was 1.0 case per 100,000 population. After adjusting for under-ascertainment and under-reporting,…
My interview with the wonderful Sasha Latypova, a pharma regulation expert, for TrialSite News
https://www.trialsitenews.com/a/dr.-meryl-nass-answers-questions-about-new-covid-19-boosters-ba4ba5-being-authorized-by-the-fda-for-the-fall-season-video-5b5ccc70